These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12568202)

  • 1. Homocysteine--are we making a mountain out of a molehill?
    Kumar AV; Lokhandwala Y
    J Assoc Physicians India; 2002 Oct; 50():1227-8. PubMed ID: 12568202
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine in uraemia--a puzzling and conflicting story.
    Suliman ME; Bárány P; Kalantar-Zadeh K; Lindholm B; Stenvinkel P
    Nephrol Dial Transplant; 2005 Jan; 20(1):16-21. PubMed ID: 15479750
    [No Abstract]   [Full Text] [Related]  

  • 3. Homocysteine levels in Pakistanis with myocardial infarction and normal healthy subjects.
    Iqbal MP
    J Coll Physicians Surg Pak; 2006 Apr; 16(4):311; author reply 311. PubMed ID: 16624205
    [No Abstract]   [Full Text] [Related]  

  • 4. Homocysteine: a risk factor for coronary artery disease?
    Marinou K; Antoniades C; Tousoulis D; Pitsavos C; Goumas G; Stefanadis C
    Hellenic J Cardiol; 2005; 46(1):59-67. PubMed ID: 15807397
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):935-9. PubMed ID: 15500438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of coronary artery disease in patients with rheumatic heart disease in the current era.
    Jose VJ; Gupta SN; Joseph G; Chandy ST; George OK; Pati PK; John B; George P
    Indian Heart J; 2004; 56(2):129-31. PubMed ID: 15377134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment selection for coronary artery disease: The collision of a belief system with evidence.
    Smith PK
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1050-3. PubMed ID: 19379965
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel risk markers and clinical practice.
    Manolio T
    N Engl J Med; 2003 Oct; 349(17):1587-9. PubMed ID: 14573728
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the extent and severity of coronary artery disease in patients with acute myocardial infarction with and without microalbuminuria.
    Lekatsas I; Kranidis A; Ioannidis G; Kalofoutis C; Tavernarakis A; Thalassinos N; Kalofoutis A; Anthopoulos L; Koulouris S
    Am J Cardiol; 2004 Aug; 94(3):334-7. PubMed ID: 15276097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression.
    Gurbel PA; Kreutz RP; Bliden KP; DiChiara J; Tantry US
    Am Heart J; 2008 Jan; 155(1):56-61. PubMed ID: 18082490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic dyslipidemia and the heart.
    Vasudevan AR; Garber AJ
    Heart Fail Clin; 2006 Jan; 2(1):37-52. PubMed ID: 17386875
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease.
    Yilmaz N; Ciçek HK; Celik A; Meram I; Kocabas R; Davutoglu V
    East Mediterr Health J; 2007; 13(3):522-35. PubMed ID: 17687824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-reactive protein and homocysteine as risk factors of atherosclerosis].
    Jarosz A; Nowicka G
    Przegl Lek; 2008; 65(6):268-72. PubMed ID: 18853656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
    van Guldener C
    Nephrol Dial Transplant; 2006 May; 21(5):1161-6. PubMed ID: 16490741
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment and predictive value of coronary artery disease testing.
    Shaw LJ; Narula J
    J Nucl Med; 2009 Aug; 50(8):1296-306. PubMed ID: 19652216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.